Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaap Verweij

Showing results (101-110 of 234) with videos related to

Pageof 24
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2002
Influence of Cremophor El on the bioavailability of intraperitoneal paclitaxelHans Gelderblom, Jaap Verweij, Desirée M van Zomeren, et al.
Clinical Pharmacology and Therapeutics|January 8, 2005
Relationship of systemic exposure to unbound docetaxel and neutropeniaSharyn D Baker, Jing Li, Albert J ten Tije, et al.
Cancer Chemotherapy and Pharmacology|December 14, 2004
A phase I and pharmacologic study of the matrix metalloproteinase inhibitor CP-471,358 in patients with advanced solid tumorsAndré Planting, Ate van der Gaast, Patrick Schöffski, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 3, 2003
Determination of irinotecan (CPT-11) and SN-38 in human whole blood and red blood cells by liquid chromatography with fluorescence detectionFloris A de Jong, Ron H J Mathijssen, Peter de Bruijn, et al.
Clinical Pharmacology and Therapeutics|October 31, 2003
Disposition of polyoxyethylated excipients in humans: implications for drug safety and formulation approachesAlbert J Ten Tije, Walter J Loos, Jaap Verweij, et al.
Cancer Biology & Therapy|May 24, 2005
Effect of ABCG2 genotype on the oral bioavailability of topotecanAlex Sparreboom, Walter J Loos, Herman Burger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
ABCG2 pharmacogenetics: ethnic differences in allele frequency and assessment of influence on irinotecan dispositionFloris A de Jong, Sharon Marsh, Ron H J Mathijssen, et al.
Cancer Chemotherapy and Pharmacology|December 20, 2008
Application of prolonged microdialysis sampling in carboplatin-treated cancer patientsInge R H M Konings, Frederike K Engels, Stefan Sleijfer, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 2007
Medicinal cannabis in oncologyFrederike K Engels, Floris A de Jong, Ron H J Mathijssen, et al.
Anti-Cancer Drugs|March 14, 2003
Red blood cells: a neglected compartment in topotecan pharmacokinetic analysisWalter J Loos, Hans Gelderblom, Jaap Verweij, et al.
Pageof 24

Showing results (101-110 of 234) with videos related to

Sort By:
Pageof 24
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2002
Influence of Cremophor El on the bioavailability of intraperitoneal paclitaxelHans Gelderblom, Jaap Verweij, Desirée M van Zomeren, et al.
Clinical Pharmacology and Therapeutics|January 8, 2005
Relationship of systemic exposure to unbound docetaxel and neutropeniaSharyn D Baker, Jing Li, Albert J ten Tije, et al.
Cancer Chemotherapy and Pharmacology|December 14, 2004
A phase I and pharmacologic study of the matrix metalloproteinase inhibitor CP-471,358 in patients with advanced solid tumorsAndré Planting, Ate van der Gaast, Patrick Schöffski, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 3, 2003
Determination of irinotecan (CPT-11) and SN-38 in human whole blood and red blood cells by liquid chromatography with fluorescence detectionFloris A de Jong, Ron H J Mathijssen, Peter de Bruijn, et al.
Clinical Pharmacology and Therapeutics|October 31, 2003
Disposition of polyoxyethylated excipients in humans: implications for drug safety and formulation approachesAlbert J Ten Tije, Walter J Loos, Jaap Verweij, et al.
Cancer Biology & Therapy|May 24, 2005
Effect of ABCG2 genotype on the oral bioavailability of topotecanAlex Sparreboom, Walter J Loos, Herman Burger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
ABCG2 pharmacogenetics: ethnic differences in allele frequency and assessment of influence on irinotecan dispositionFloris A de Jong, Sharon Marsh, Ron H J Mathijssen, et al.
Cancer Chemotherapy and Pharmacology|December 20, 2008
Application of prolonged microdialysis sampling in carboplatin-treated cancer patientsInge R H M Konings, Frederike K Engels, Stefan Sleijfer, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 2007
Medicinal cannabis in oncologyFrederike K Engels, Floris A de Jong, Ron H J Mathijssen, et al.
Anti-Cancer Drugs|March 14, 2003
Red blood cells: a neglected compartment in topotecan pharmacokinetic analysisWalter J Loos, Hans Gelderblom, Jaap Verweij, et al.
Pageof 24